Cathie Wood's ARK Invest bought Recursion Pharmaceuticals and CRISPR Therapeutics while selling PagerDuty, Teradyne, and Salesforce on8, 2026.
AI tools promise to compress drug development timelines from decades to years, accelerating data analysis and testing for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results